ID   KP-2/CMV-Luc
AC   CVCL_4W98
DR   cancercelllines; CVCL_4W98
DR   JCRB; JCRB1491
DR   JCRB; NIHS0715
DR   Wikidata; Q54900360
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Asp415Glufs*20 (c.1245_1248delCAGA); ClinVar=VCV000142253; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Discontinued: JCRB; NIHS0715; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1491
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3850; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3004 ! KP-2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 15
//